NSE ScannerChemicals · Chemicals: Major Diversified · NSE: BIOPOL · data 2026-10-31
Biopol Chemicals Ltd.
In plain words
Price: 65.2% below its 52-week high of ₹133.75.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹81 cr |
| Net profit (last 12 months) | ₹9 cr |
| Sales growth, 3 years (yearly) | 61.3% |
| Profit growth, 3 years (yearly) | 155.5% |
At a glance
P/E 5.6, P/B 1.0, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 28.3%, ROCE 39.0%, operating margin 16.5%: how much profit it earns on the money it uses.
Debt/equity 0.17, Profit growth 155.5% and sales growth 61.3% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (28.3%).
- Profit grew 155.5% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: Net −₹0.39 cr in bulk/block deals over 90 days (0 net buying days, 2 net selling days): more sold than bought.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal
- 3 Sept 26Deal Bulk deal: NEO APEX SHARE BROKING SERVICES LLP sold ₹0.15 cr +10.1% next session
- 2 Sept 26Deal Bulk deal: NEO APEX SHARE BROKING SERVICES LLP sold ₹0.24 cr -5.5% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Biopol Chemicals Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.17.
What is Biopol Chemicals Ltd.'s P/E ratio?
About 5.6, based on the last 12 months' earnings and a price of ₹46.5 (data 2026-10-31).
What is the 52-week high and low of Biopol Chemicals Ltd.?
The 52-week high is ₹133.75 and the 52-week low is ₹39.5.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Biopol Chemicals Ltd. | ₹46.5 | ₹50 cr | 5.6 | 1 | 28.3% | 39% | 0.17 | -58.1% |
| Paragon Fine And Speciality Chemical Limited | ₹48.8 | ₹95 cr | 10.6 | 1 | 9.6% | 12.1% | 0.01 | -12.4% |
| Indian Emulsifiers Ltd. | ₹35.5 | ₹65 cr | 3.1 | — | 14.2% | 17.7% | 0.37 | -66.2% |
| Ambica Agarbathies & Aroma Industries Ltd. | ₹22.91 | ₹40 cr | 11.5 | — | 3.1% | 4.5% | 0.85 | -9.9% |
| Shiva Global Agro Industries Limited | ₹35.85 | ₹38 cr | — | — | 0% | -20.3% | 0.27 | -3.6% |
| Seya Industries Ltd. | ₹11.69 | ₹30 cr | — | — | -0.4% | -1.4% | 0.94 | -39.5% |
Compare BIOPOL with PARAGON in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BIOPOL in NSE Scanner →